Experienced in Hypophosphatemia

Brigette B. Ma

Sar, CN 
Experienced in Hypophosphatemia
Sar, CN 
OverviewLocationsClinical Research

Overview

Brigette Ma practices in Sar, China. Ms. Ma is rated as an Experienced expert by MediFind in the treatment of Hypophosphatemia. Her top areas of expertise are Nasopharyngeal Carcinoma, Mononucleosis, Colorectal Cancer, and Bacterial Prostatitis.

Her clinical research consists of co-authoring 44 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Hypophosphatemia.

Gender
Female

Locations

Sar, China
Other Locations
State Key Laboratory Of Digestive Disease, Hong Kong, Lika, China
State Key Laboratory Of Translational Oncology, China
Nanjing, China
30-32 Ngan Shing Street, New Territories, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
An Open-Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
Enrollment Status: Terminated
Publish Date: October 03, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Gemcitabine, Nivolumab
Study Phase: Phase 3
A Phase II Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma
A Phase II Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma
Enrollment Status: Withdrawn
Publish Date: May 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
Multicenter Phase II Study of Nivolumab in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Multicenter Phase II Study of Nivolumab in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Enrollment Status: Completed
Publish Date: September 13, 2019
Intervention Type: Biological, Other
Study Phase: Phase 2
View 2 Less Clinical Trials

44 Total Publications

Author Correction: Evolving landscape of nasopharyngeal carcinoma therapy.
Author Correction: Evolving landscape of nasopharyngeal carcinoma therapy.
Journal: Nature cancer
Published: October 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ma's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile